吸入式一酸化窒素デリバリー装置のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Inhaled Nitric Oxide Delivery Device Market Insights, Forecast to 2028

• レポートコード：QY2207E09593 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の吸入式一酸化窒素デリバリー装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に吸入式一酸化窒素デリバリー装置の世界市場のxxx％を占める「子供用吸入一酸化窒素デリバリー装置」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「低酸素性呼吸不全（HRF）」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の吸入式一酸化窒素デリバリー装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの吸入式一酸化窒素デリバリー装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの吸入式一酸化窒素デリバリー装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 吸入式一酸化窒素デリバリー装置のグローバル主要メーカーには、Mallinckrodt Pharmaceuticals、Getinge、Vero Biotech、LINDE、Beyond Air、Air Liquide Healthcare、Circassia Pharmaceuticals、NU MED、Bellerophon Therapeutics、Praxair Technology Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 吸入式一酸化窒素デリバリー装置市場は、種類と用途によって区分されます。世界の吸入式一酸化窒素デリバリー装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 子供用吸入一酸化窒素デリバリー装置、成人用吸入一酸化窒素デリバリー装置 【用途別セグメント】 低酸素性呼吸不全（HRF）、急性低酸素性呼吸不全（AHRF）、慢性閉塞性肺疾患（COPD）、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 吸入式一酸化窒素デリバリー装置製品概要 - 種類別市場（子供用吸入一酸化窒素デリバリー装置、成人用吸入一酸化窒素デリバリー装置） - 用途別市場（低酸素性呼吸不全（HRF）、急性低酸素性呼吸不全（AHRF）、慢性閉塞性肺疾患（COPD）、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の吸入式一酸化窒素デリバリー装置販売量予測2017-2028 - 世界の吸入式一酸化窒素デリバリー装置売上予測2017-2028 - 吸入式一酸化窒素デリバリー装置の地域別販売量 - 吸入式一酸化窒素デリバリー装置の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別吸入式一酸化窒素デリバリー装置販売量 - 主要メーカー別吸入式一酸化窒素デリバリー装置売上 - 主要メーカー別吸入式一酸化窒素デリバリー装置価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（子供用吸入一酸化窒素デリバリー装置、成人用吸入一酸化窒素デリバリー装置） - 吸入式一酸化窒素デリバリー装置の種類別販売量 - 吸入式一酸化窒素デリバリー装置の種類別売上 - 吸入式一酸化窒素デリバリー装置の種類別価格 ・用途別市場規模（低酸素性呼吸不全（HRF）、急性低酸素性呼吸不全（AHRF）、慢性閉塞性肺疾患（COPD）、その他） - 吸入式一酸化窒素デリバリー装置の用途別販売量 - 吸入式一酸化窒素デリバリー装置の用途別売上 - 吸入式一酸化窒素デリバリー装置の用途別価格 ・北米市場 - 北米の吸入式一酸化窒素デリバリー装置市場規模（種類別、用途別） - 主要国別の吸入式一酸化窒素デリバリー装置市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの吸入式一酸化窒素デリバリー装置市場規模（種類別、用途別） - 主要国別の吸入式一酸化窒素デリバリー装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の吸入式一酸化窒素デリバリー装置市場規模（種類別、用途別） - 主要国別の吸入式一酸化窒素デリバリー装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の吸入式一酸化窒素デリバリー装置市場規模（種類別、用途別） - 主要国別の吸入式一酸化窒素デリバリー装置市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの吸入式一酸化窒素デリバリー装置市場規模（種類別、用途別） - 主要国別の吸入式一酸化窒素デリバリー装置市場規模（トルコ、サウジアラビア） ・企業情報 Mallinckrodt Pharmaceuticals、Getinge、Vero Biotech、LINDE、Beyond Air、Air Liquide Healthcare、Circassia Pharmaceuticals、NU MED、Bellerophon Therapeutics、Praxair Technology Inc. ・産業チェーン及び販売チャネル分析 - 吸入式一酸化窒素デリバリー装置の産業チェーン分析 - 吸入式一酸化窒素デリバリー装置の原材料 - 吸入式一酸化窒素デリバリー装置の生産プロセス - 吸入式一酸化窒素デリバリー装置の販売及びマーケティング - 吸入式一酸化窒素デリバリー装置の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 吸入式一酸化窒素デリバリー装置の産業動向 - 吸入式一酸化窒素デリバリー装置のマーケットドライバー - 吸入式一酸化窒素デリバリー装置の課題 - 吸入式一酸化窒素デリバリー装置の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Inhaled Nitric Oxide Delivery Device Market
Due to the COVID-19 pandemic, the global Inhaled Nitric Oxide Delivery Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Inhaled Nitric Oxide Delivery Device for Children accounting for % of the Inhaled Nitric Oxide Delivery Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hypoxic Respiratory Failure (HRF) segment is altered to an % CAGR throughout this forecast period.
China Inhaled Nitric Oxide Delivery Device market size is valued at US$ million in 2021, while the US and Europe Inhaled Nitric Oxide Delivery Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Inhaled Nitric Oxide Delivery Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED and Bellerophon Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Inhaled Nitric Oxide Delivery Device Scope and Segment
Inhaled Nitric Oxide Delivery Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Inhaled Nitric Oxide Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Segment by Application
Hypoxic Respiratory Failure (HRF)
Acute Hypoxemic Respiratory Failure (AHRF)
Chronic Obstructive Pulmonary Disease (COPD)
Others
By Company
Mallinckrodt Pharmaceuticals
Getinge
Vero Biotech
LINDE
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
NU MED
Bellerophon Therapeutics
Praxair Technology Inc.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Inhaled Nitric Oxide Delivery Device Product Introduction
1.2 Market by Type
1.2.1 Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inhaled Nitric Oxide Delivery Device for Children
1.2.3 Inhaled Nitric Oxide Delivery Device for Adults
1.3 Market by Application
1.3.1 Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hypoxic Respiratory Failure (HRF)
1.3.3 Acute Hypoxemic Respiratory Failure (AHRF)
1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhaled Nitric Oxide Delivery Device Sales Estimates and Forecasts 2017-2028
2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inhaled Nitric Oxide Delivery Device Sales by Region
2.4.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022)
2.4.2 Global Sales Inhaled Nitric Oxide Delivery Device by Region (2023-2028)
2.5 Global Inhaled Nitric Oxide Delivery Device Revenue by Region
2.5.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022)
2.5.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturers
3.1.1 Global Top Inhaled Nitric Oxide Delivery Device Manufacturers by Sales (2017-2022)
3.1.2 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhaled Nitric Oxide Delivery Device in 2021
3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers
3.2.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inhaled Nitric Oxide Delivery Device Revenue in 2021
3.3 Global Inhaled Nitric Oxide Delivery Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhaled Nitric Oxide Delivery Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type
4.1.1 Global Inhaled Nitric Oxide Delivery Device Historical Sales by Type (2017-2022)
4.1.2 Global Inhaled Nitric Oxide Delivery Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
4.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type
4.2.1 Global Inhaled Nitric Oxide Delivery Device Historical Revenue by Type (2017-2022)
4.2.2 Global Inhaled Nitric Oxide Delivery Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
4.3 Global Inhaled Nitric Oxide Delivery Device Price by Type
4.3.1 Global Inhaled Nitric Oxide Delivery Device Price by Type (2017-2022)
4.3.2 Global Inhaled Nitric Oxide Delivery Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application
5.1.1 Global Inhaled Nitric Oxide Delivery Device Historical Sales by Application (2017-2022)
5.1.2 Global Inhaled Nitric Oxide Delivery Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
5.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application
5.2.1 Global Inhaled Nitric Oxide Delivery Device Historical Revenue by Application (2017-2022)
5.2.2 Global Inhaled Nitric Oxide Delivery Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
5.3 Global Inhaled Nitric Oxide Delivery Device Price by Application
5.3.1 Global Inhaled Nitric Oxide Delivery Device Price by Application (2017-2022)
5.3.2 Global Inhaled Nitric Oxide Delivery Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inhaled Nitric Oxide Delivery Device Market Size by Type
6.1.1 North America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
6.1.2 North America Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2028)
6.2 North America Inhaled Nitric Oxide Delivery Device Market Size by Application
6.2.1 North America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
6.2.2 North America Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2028)
6.3 North America Inhaled Nitric Oxide Delivery Device Market Size by Country
6.3.1 North America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2028)
6.3.2 North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Inhaled Nitric Oxide Delivery Device Market Size by Type
7.1.1 Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
7.1.2 Europe Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2028)
7.2 Europe Inhaled Nitric Oxide Delivery Device Market Size by Application
7.2.1 Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
7.2.2 Europe Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2028)
7.3 Europe Inhaled Nitric Oxide Delivery Device Market Size by Country
7.3.1 Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2028)
7.3.2 Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Size by Type
8.1.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2028)
8.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Size by Application
8.2.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2028)
8.3 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Size by Region
8.3.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Inhaled Nitric Oxide Delivery Device Market Size by Type
9.1.1 Latin America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
9.1.2 Latin America Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2028)
9.2 Latin America Inhaled Nitric Oxide Delivery Device Market Size by Application
9.2.1 Latin America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
9.2.2 Latin America Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2028)
9.3 Latin America Inhaled Nitric Oxide Delivery Device Market Size by Country
9.3.1 Latin America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2028)
9.3.2 Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size by Type
10.1.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size by Application
10.2.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size by Country
10.3.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Overview
11.1.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mallinckrodt Pharmaceuticals Recent Developments
11.2 Getinge
11.2.1 Getinge Corporation Information
11.2.2 Getinge Overview
11.2.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Getinge Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Getinge Recent Developments
11.3 Vero Biotech
11.3.1 Vero Biotech Corporation Information
11.3.2 Vero Biotech Overview
11.3.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Vero Biotech Recent Developments
11.4 LINDE
11.4.1 LINDE Corporation Information
11.4.2 LINDE Overview
11.4.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LINDE Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LINDE Recent Developments
11.5 Beyond Air
11.5.1 Beyond Air Corporation Information
11.5.2 Beyond Air Overview
11.5.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Beyond Air Recent Developments
11.6 Air Liquide Healthcare
11.6.1 Air Liquide Healthcare Corporation Information
11.6.2 Air Liquide Healthcare Overview
11.6.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Air Liquide Healthcare Recent Developments
11.7 Circassia Pharmaceuticals
11.7.1 Circassia Pharmaceuticals Corporation Information
11.7.2 Circassia Pharmaceuticals Overview
11.7.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Circassia Pharmaceuticals Recent Developments
11.8 NU MED
11.8.1 NU MED Corporation Information
11.8.2 NU MED Overview
11.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 NU MED Recent Developments
11.9 Bellerophon Therapeutics
11.9.1 Bellerophon Therapeutics Corporation Information
11.9.2 Bellerophon Therapeutics Overview
11.9.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bellerophon Therapeutics Recent Developments
11.10 Praxair Technology Inc.
11.10.1 Praxair Technology Inc. Corporation Information
11.10.2 Praxair Technology Inc. Overview
11.10.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Praxair Technology Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inhaled Nitric Oxide Delivery Device Industry Chain Analysis
12.2 Inhaled Nitric Oxide Delivery Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhaled Nitric Oxide Delivery Device Production Mode & Process
12.4 Inhaled Nitric Oxide Delivery Device Sales and Marketing
12.4.1 Inhaled Nitric Oxide Delivery Device Sales Channels
12.4.2 Inhaled Nitric Oxide Delivery Device Distributors
12.5 Inhaled Nitric Oxide Delivery Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhaled Nitric Oxide Delivery Device Industry Trends
13.2 Inhaled Nitric Oxide Delivery Device Market Drivers
13.3 Inhaled Nitric Oxide Delivery Device Market Challenges
13.4 Inhaled Nitric Oxide Delivery Device Market Restraints
14 Key Findings in The Global Inhaled Nitric Oxide Delivery Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inhaled Nitric Oxide Delivery Device for Children
Table 3. Major Manufacturers of Inhaled Nitric Oxide Delivery Device for Adults
Table 4. Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022) & (K Units)
Table 7. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2022)
Table 8. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2023-2028) & (K Units)
Table 9. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2023-2028)
Table 10. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2017-2022)
Table 12. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2023-2028)
Table 14. Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Inhaled Nitric Oxide Delivery Device Sales Share by Manufacturers (2017-2022)
Table 16. Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Manufacturers (2017-2022)
Table 18. Inhaled Nitric Oxide Delivery Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Inhaled Nitric Oxide Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Inhaled Nitric Oxide Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide Delivery Device as of 2021)
Table 21. Inhaled Nitric Oxide Delivery Device Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Inhaled Nitric Oxide Delivery Device Product Offered
Table 23. Date of Manufacturers Enter into Inhaled Nitric Oxide Delivery Device Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 26. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 27. Global Inhaled Nitric Oxide Delivery Device Sales Share by Type (2017-2022)
Table 28. Global Inhaled Nitric Oxide Delivery Device Sales Share by Type (2023-2028)
Table 29. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2017-2022)
Table 32. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2023-2028)
Table 33. Inhaled Nitric Oxide Delivery Device Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Inhaled Nitric Oxide Delivery Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 36. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 37. Global Inhaled Nitric Oxide Delivery Device Sales Share by Application (2017-2022)
Table 38. Global Inhaled Nitric Oxide Delivery Device Sales Share by Application (2023-2028)
Table 39. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2017-2022)
Table 42. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2023-2028)
Table 43. Inhaled Nitric Oxide Delivery Device Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Inhaled Nitric Oxide Delivery Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 46. North America Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 47. North America Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Inhaled Nitric Oxide Delivery Device Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 50. North America Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 51. North America Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Inhaled Nitric Oxide Delivery Device Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 54. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2023-2028) & (K Units)
Table 55. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 58. Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 59. Europe Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Inhaled Nitric Oxide Delivery Device Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 62. Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 63. Europe Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Inhaled Nitric Oxide Delivery Device Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 66. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2023-2028) & (K Units)
Table 67. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Inhaled Nitric Oxide Delivery Device Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2023-2028) & (US$ Million)
Table 105. Mallinckrodt Pharmaceuticals Corporation Information
Table 106. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 107. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Mallinckrodt Pharmaceuticals Recent Developments
Table 110. Getinge Corporation Information
Table 111. Getinge Description and Major Businesses
Table 112. Getinge Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Getinge Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Getinge Recent Developments
Table 115. Vero Biotech Corporation Information
Table 116. Vero Biotech Description and Major Businesses
Table 117. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Vero Biotech Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Vero Biotech Recent Developments
Table 120. LINDE Corporation Information
Table 121. LINDE Description and Major Businesses
Table 122. LINDE Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. LINDE Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. LINDE Recent Developments
Table 125. Beyond Air Corporation Information
Table 126. Beyond Air Description and Major Businesses
Table 127. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Beyond Air Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Beyond Air Recent Developments
Table 130. Air Liquide Healthcare Corporation Information
Table 131. Air Liquide Healthcare Description and Major Businesses
Table 132. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Air Liquide Healthcare Recent Developments
Table 135. Circassia Pharmaceuticals Corporation Information
Table 136. Circassia Pharmaceuticals Description and Major Businesses
Table 137. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Circassia Pharmaceuticals Recent Developments
Table 140. NU MED Corporation Information
Table 141. NU MED Description and Major Businesses
Table 142. NU MED Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. NU MED Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. NU MED Recent Developments
Table 145. Bellerophon Therapeutics Corporation Information
Table 146. Bellerophon Therapeutics Description and Major Businesses
Table 147. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Bellerophon Therapeutics Recent Developments
Table 150. Praxair Technology Inc. Corporation Information
Table 151. Praxair Technology Inc. Description and Major Businesses
Table 152. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Praxair Technology Inc. Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Inhaled Nitric Oxide Delivery Device Distributors List
Table 158. Inhaled Nitric Oxide Delivery Device Customers List
Table 159. Inhaled Nitric Oxide Delivery Device Market Trends
Table 160. Inhaled Nitric Oxide Delivery Device Market Drivers
Table 161. Inhaled Nitric Oxide Delivery Device Market Challenges
Table 162. Inhaled Nitric Oxide Delivery Device Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhaled Nitric Oxide Delivery Device Product Picture
Figure 3. Global Inhaled Nitric Oxide Delivery Device Market Share by Type in 2021 & 2028
Figure 3. Inhaled Nitric Oxide Delivery Device for Children Product Picture
Figure 4. Inhaled Nitric Oxide Delivery Device for Adults Product Picture
Figure 5. Global Inhaled Nitric Oxide Delivery Device Market Share by Application in 2021 & 2028
Figure 6. Hypoxic Respiratory Failure (HRF)
Figure 7. Acute Hypoxemic Respiratory Failure (AHRF)
Figure 8. Chronic Obstructive Pulmonary Disease (COPD)
Figure 9. Others
Figure 10. Inhaled Nitric Oxide Delivery Device Report Years Considered
Figure 11. Global Inhaled Nitric Oxide Delivery Device Sales 2017-2028 (K Units)
Figure 12. Global Inhaled Nitric Oxide Delivery Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Inhaled Nitric Oxide Delivery Device Revenue 2017-2028 (US$ Million)
Figure 14. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2022)
Figure 16. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2023-2028)
Figure 17. North America Inhaled Nitric Oxide Delivery Device Sales YoY (2017-2028) & (K Units)
Figure 18. North America Inhaled Nitric Oxide Delivery Device Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Inhaled Nitric Oxide Delivery Device Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Inhaled Nitric Oxide Delivery Device Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Inhaled Nitric Oxide Delivery Device Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Inhaled Nitric Oxide Delivery Device Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Inhaled Nitric Oxide Delivery Device Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Inhaled Nitric Oxide Delivery Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Inhaled Nitric Oxide Delivery Device in the World: Market Share by Inhaled Nitric Oxide Delivery Device Revenue in 2021
Figure 29. Global Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 31. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
Figure 32. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 33. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
Figure 34. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 35. North America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
Figure 36. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 37. North America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
Figure 38. North America Inhaled Nitric Oxide Delivery Device Sales Share by Country (2017-2028)
Figure 39. North America Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2017-2028)
Figure 40. United States Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 43. Europe Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
Figure 44. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 45. Europe Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
Figure 46. Europe Inhaled Nitric Oxide Delivery Device Sales Share by Country (2017-2028)
Figure 47. Europe Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2017-2028)
Figure 48. Germany Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 49. France Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue Share by Region (2017-2028)
Figure 59. China Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 62. India Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 69. Latin America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 71. Latin America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Inhaled Nitric Oxide Delivery Device Sales Share by Country (2017-2028)
Figure 73. Latin America Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2017-2028)
Figure 74. Mexico Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2017-2028)
Figure 83. Turkey Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (US$ Million)
Figure 86. Inhaled Nitric Oxide Delivery Device Value Chain
Figure 87. Inhaled Nitric Oxide Delivery Device Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---